VRNA logo

Verona Pharma (VRNA) Accounts Payable

Annual Accounts Payable

$3.49 M
+$582.00 K+20.00%

31 December 2023

VRNA Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$6.83 M
+$2.68 M+64.52%

30 September 2024

VRNA Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VRNA Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.0%+730.0%
3 y3 years+1861.8%+10000.0%
5 y5 years-3.1%-52.1%

VRNA Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-65.2%+1861.8%-32.0%>+9999.0%
5 y5 years-65.2%+1861.8%-52.1%>+9999.0%
alltimeall time-65.2%+5143.2%-52.1%>+9999.0%

Verona Pharma Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$6.83 M(+64.5%)
June 2024
-
$4.15 M(-10.7%)
Mar 2024
-
$4.65 M(+33.2%)
Dec 2023
$3.49 M(+20.0%)
$3.49 M(+324.3%)
Sept 2023
-
$823.00 K(-67.0%)
June 2023
-
$2.49 M(-65.6%)
Mar 2023
-
$7.24 M(+148.7%)
Dec 2022
$2.91 M(-71.0%)
$2.91 M(-63.6%)
Sept 2022
-
$8.00 M(-14.5%)
June 2022
-
$9.36 M(+16.1%)
Mar 2022
-
$8.06 M(-19.7%)
Dec 2021
$10.04 M(+5542.7%)
$10.04 M(>+9900.0%)
Sept 2021
-
$9000.00(-73.5%)
June 2021
-
$34.00 K(-93.7%)
Mar 2021
-
$541.00 K(+203.9%)
Dec 2020
$178.00 K(-90.8%)
$178.00 K(-98.7%)
Sept 2020
-
$14.19 M(+62.2%)
June 2020
-
$8.75 M(+6.9%)
Mar 2020
-
$8.19 M(+324.0%)
Dec 2019
$1.93 M(-46.4%)
$1.93 M(-86.5%)
Sept 2019
-
$14.26 M(+28.0%)
June 2019
-
$11.15 M(+76.2%)
Mar 2019
-
$6.33 M(+75.6%)
Dec 2018
$3.60 M
$3.60 M(-51.8%)
Sept 2018
-
$7.47 M(+3.3%)
June 2018
-
$7.23 M(-10.5%)
DateAnnualQuarterly
Mar 2018
-
$8.08 M(+392.6%)
Dec 2017
$1.64 M(+84.9%)
$1.64 M(-74.2%)
Sept 2017
-
$6.37 M(-7.8%)
June 2017
-
$6.91 M(+678.5%)
Dec 2016
$887.10 K(-53.3%)
$887.10 K(-47.4%)
June 2016
-
$1.69 M(-11.1%)
Dec 2015
$1.90 M(+232.8%)
$1.90 M(+111.4%)
June 2015
-
$898.30 K(+57.4%)
Dec 2014
$570.60 K(+4.9%)
$570.60 K(-17.4%)
June 2014
-
$690.40 K(+27.0%)
Dec 2013
$543.80 K(+148.1%)
$543.80 K(+105.0%)
June 2013
-
$265.30 K(+21.0%)
Dec 2012
$219.20 K(+58.6%)
$219.20 K(+39.5%)
June 2012
-
$157.10 K(+13.7%)
Dec 2011
$138.20 K(-37.0%)
$138.20 K(-69.9%)
June 2011
-
$459.70 K(+109.7%)
Dec 2010
$219.20 K(+15.9%)
$219.20 K(+124.1%)
June 2010
-
$97.80 K(-48.3%)
Dec 2009
$189.20 K(+163.5%)
$189.20 K(+101.7%)
June 2009
-
$93.80 K(+30.6%)
Dec 2008
$71.80 K(-63.0%)
$71.80 K(-87.8%)
June 2008
-
$587.10 K(+202.2%)
Dec 2007
$194.30 K(+191.7%)
$194.30 K(+38.2%)
June 2007
-
$140.60 K(+111.1%)
Dec 2006
$66.60 K
$66.60 K(-73.1%)
June 2006
-
$247.60 K(+1880.8%)
June 2005
-
$12.50 K

FAQ

  • What is Verona Pharma annual accounts payable?
  • What is the all time high annual accounts payable for Verona Pharma?
  • What is Verona Pharma annual accounts payable year-on-year change?
  • What is Verona Pharma quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Verona Pharma?
  • What is Verona Pharma quarterly accounts payable year-on-year change?

What is Verona Pharma annual accounts payable?

The current annual accounts payable of VRNA is $3.49 M

What is the all time high annual accounts payable for Verona Pharma?

Verona Pharma all-time high annual accounts payable is $10.04 M

What is Verona Pharma annual accounts payable year-on-year change?

Over the past year, VRNA annual accounts payable has changed by +$582.00 K (+20.00%)

What is Verona Pharma quarterly accounts payable?

The current quarterly accounts payable of VRNA is $6.83 M

What is the all time high quarterly accounts payable for Verona Pharma?

Verona Pharma all-time high quarterly accounts payable is $14.26 M

What is Verona Pharma quarterly accounts payable year-on-year change?

Over the past year, VRNA quarterly accounts payable has changed by +$6.01 M (+730.01%)